U.S. Markets closed

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.62-0.16 (-1.48%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue641--
Cost of Revenue490--
Gross Profit151--
Operating Expenses
Research Development7,7094,7813,277
Selling General and Administrative2,4522,6022,629
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-10,010-7,383-5,906
Income from Continuing Operations
Total Other Income/Expenses Net474168225
Earnings Before Interest and Taxes-9,536-7,215-5,681
Interest Expense931811
Income Before Tax-9,629-7,233-5,692
Income Tax Expense1,335-14
Minority Interest---
Net Income From Continuing Ops-10,964-7,232-5,696
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,964-7,232-5,696
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,964-7,232-5,696